Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Dopamine Buffering Capacity Measured by phMRI as a Novel Biomarker of Disease Progression in PD

NCT03205956 is registered in ClinicalTrials.gov with Kevin J. Black, MD as lead sponsor.

NCT NCT03205956
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03205956 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Dopamine Buffering Capacity Measured by phMRI as a Novel Biomarker of Disease Progression in PD
Lead sponsor
Kevin J. Black, MD
Phase
Phase 1
Overall status
Completed
Start date
October 19, 2017
Completion date
October 19, 2019
Enrollment
31 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

parkinson's disease